Navigation Links
Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
Date:9/10/2008

Mega-dose Resveratrol, Sirtuin1 gene Target Discredited; Lower Dose, Array

of Small Molecules (Longevinex(R)) Exert Greater Effect

SAN DIMAS, Calif., Sept. 10 /PRNewswire/ -- While the red wine molecule resveratrol (rez-vair-ah-trawl) has recently attracted scientific and public attention as a longevity molecule that allegedly mimics the effects of a calorie-restricted diet, the science surrounding this molecule has taken a dramatic turn in recent months, according to Bill Sardi, spokesperson for Longevinex(R) (long-jev-in-ex), a major brand resveratrol supplement.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU004)

Published research studies now show:

-- Mice fed high-dose resveratrol did not live as long as mice fed a plain standard calorie diet. Animals on the lower dose (360 milligram human equivalent) lived longer than those on the higher dose (1565 mg) of resveratrol. [Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span. Cell Metabolism 2008 Aug;8(2):157-68]

-- The Sirtuin1 gene, once called the "holy grail" of longevity and believed to be the gene target of calorie restriction, has not been found to be universally activated by a limited calorie diet. A calorie-restricted diet results in more Sirtuin1 gene-derived proteins by exerting stabilization effects, not by activation of the gene. This new finding throws a scientific cloud over the use of Sirtuin1 gene activation tests as a measure of resveratrol activity. [Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008 Jul 1; 22(13):1753-7; Regulation of SIRT1 protein levels by nutrient availability. FEBS Letters. 2008 Jul 9; 582(16):2417-23]

-- While researchers once advised consumers to wait for stronger synthetic molecules that can stimulate the Sirtuin1 gene by 1
'/>"/>

SOURCE Resveratrol Partners, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
2. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
3. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
4. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
5. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
6. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
7. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
8. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
9. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
10. Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
11. Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2009).../ -- Calixa Therapeutics Inc. today announced the ...in patients with complicated urinary tract infecti...cephalosporin antibiotic with excellent in vitro ...inosa , including drug resistant isolates. Calixa... for serious bacterial infections in hospitalized ...
(Date:6/29/2009)...Biotherapeutics Based On Naturally Resected tRNA S... -- Pangu BioPharma, a subsidiary of aTyr Pharma i...rd patent application on proprietary, naturally oc...h tRNA synthetases are universal and essential com...l organisms, human synthetases have naturally occu...
(Date:6/26/2009)...OSAKA, Japan, June 27, 2009 Takeda...nnounced that Takeda Global Research & Develop....S.) subsidiary received on June 26 (U.S. time) a ...ug Administration (FDA) regarding the Company,s Ne...ve dipeptidyl peptidase IV (DPP-4) inhibitor under...
(Date:6/25/2009)...perts Slated to Attend First National Symposium - ... first national symposium designed to explore the ...week in New York City when thirteen top experts ga...espective fields. The SUNY Youth Sports Institute...h impacts that the $5 billion-a-year energy drink ...
Breaking Medicine Technology:Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 1Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 2Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2485 1Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2485 2Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2485 3In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Span 2481 1In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Span 2481 2Book on weeds and invasive plants discusses how to manage them using ecological approaches 620 1Book on weeds and invasive plants discusses how to manage them using ecological approaches 620 2Book on weeds and invasive plants discusses how to manage them using ecological approaches 620 3
...E)--Mar 20, 2007 - Arrowhead,Research Corporation ...subsidiary Calando Pharmaceuticals has published,r...of Sciences,(PNAS) of the first non-human primate ...o,s lead siRNA therapeutic candidate., Calando is ...ymeric delivery systems and siRNA design to create...
...tem, dermal patch and a direct,current power sou...LE, March 20, 2007 /PRNewswire/ -- Dharma Therapeu...l drug delivery company,and wholly owned subsidi..., Tokyo, Japan announced that its active transderm...ine and epinephrine,through the skin via a mild ...
Other Medicine Technology:Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 2Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 3Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 2Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 3
(Date:7/3/2009)... July 3 Bertalan Mesko, medical bl...e e-guide for medical professionals focusing on ...dical conferences are expensive and patients are a...is eGuide helps doctors enter a virtual realm and ...ee as Second Life provides opportunities for case ...
(Date:7/3/2009)... Republicans on the Sen...health care reform legislation that would eliminat... many women could lose coverage for abortion servi...s. Plus, millions of uninsured women will still la... promised a better quality of life. , , If thes...
(Date:7/3/2009)... ReverseAges.com launches new content to includ...atigue, and how to best deal with these health iss...EB) July 3, 2009 -- ReverseAges.com has recently l... the dangers of common health issues such as high ... variety of factors, and the new content on Revers...
(Date:7/2/2009)...ore,s Bioprocessing Technology Institute (BTI) hav...apoptosis inhibitory molecule" (FAIM), protects bo...ammed cell death. , Their research is published...ation . , The scientists, Jianxin Huo, Ph.D., an...cess may possibly be manipulated for clinical appl...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2
...that practitioners don’t have to use a lot of forc...ponse // as the body has its own energy or "biomag... system. That field can be altered by acupuncture ...opathy, massage, and even by the therapists' own p...
...e might be another use for cell phones that come c...ations.// Swiss researchers who used the phone cam...remote locations say doctors felt fairly comfortab...s. The study involved 52 patients with 61 chronic ...
...tudy researchers say a three-day regimen of the an...t as effective // as ciprofloxacin (Cipro) at trea...The most common bacterial infections for women are...tions. Treating the problem has become increasingl...
... now that after delivery depressions, that had pla... due to the trauma of the delivery. As a result of...ned caesarian birth to avoid the depression. A new... British Medical Journal says that this may not be...
Other Medicine News:
Double round silicone drain with trocar, 49 in. long, with 12.25 in. (30.5 cm) hole pattern
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Used for cholangiography and bile stone removal using fluoroscopy. Dual lumen catheter design allows concomitant fluoroscopic biliary imaging and wire basket placement for stone extraction. Supplied
Medicine Products: